Exor NV, the investment arm of Italy's Agnelli family, has increased its stake in health technology company Philips to 18.7%, ...
Koninklijke Philips tackles challenges in China while focusing on AI and cost-cutting. Find out why PHG stock is a buy with ...
Make your bedroom a sleep sanctuary Make your bedroom a place which is designed to promote sleep. Block out loud sounds from outside or try using earplugs or white noise if you need to drown out ...
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...
Four guys shivering together. That freezing night, around the campfire, thinking i might die in my sleep." He said that was when his survival instinct kicked in, prompting him to urge his three ...
The FDA recall notification advised that all customers should stop using the Tack endovascular system immediately and that Philips will no longer distribute the system for use. According to the ...
The Food and Drug Administration has labeled a recall of Philips’ Tack Endovascular Systems as a Class l, which is the most serious kind of recall. There have been 20 reported injuries and no ...
Philips stopped selling an implant used to repair damaged arteries after reports of 20 injuries and some devices needing to be removed. The Food and Drug Administration said in a Monday recall notice ...
Philips is pulling from the market an implant designed to help repair the interior of damaged blood vessels following a serious product recall. The company’s Tack endovascular system includes a ...
Philips will no longer sell its Tack endovascular system in the US following a Class I recall by the US Food and Drug Administration (FDA). Class I is the most serious designation for a recall ...
Class I is the most serious designation for a recall issued by the FDA. Image credit: Shutterstock / OleksSH. Philips will no longer sell its Tack endovascular system in the US following a Class I ...
[Image from Philips] The FDA has deemed a recall of the Philips (NYSE: PHG) + Tack endovascular system Class I, the most serious kind. This recall involves removing devices from use and sale.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results